PolyOne Expands Healthcare Portfolio with Biomerics' Specialty Medical Solutions
June 2, 2014
"Biomerics' Quadra biomaterials are an excellent complement to our healthcare portfolio. These highly biocompatible polymers will enhance our ability to help our customers accelerate speed-to-market, meet or exceed product performance requirements and navigate regulatory approvals more confidently," said
Thermoplastic polyurethanes from Biomerics are used in a variety of medical device applications such as vascular access catheters, introducers, drainage catheters, interventional radiology devices, fluid management, coatings, balloons and wound care. They are available in a wide range of colors and offer a spectrum of performance characteristics.
In this press release, statements that are not reported financial results or other historical information are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. They use words such as "will," "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," and other words and terms of similar meaning in connection with any discussion of future operating or financial condition, performance and/or sales. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: the final amount of charges resulting from the planned North American asset realignment and the Company's ability to realize anticipated savings and operational benefits from the asset realignment; our ability to achieve the strategic and other objectives relating to the acquisition of
We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the
Investor Relations Contact: Isaac D. DeLuca, Vice President, Investor Relations, PolyOne Corporation, +1 440-930-1226, email@example.com; Corporate Media Contact: Kyle G. Rose, Director, Corporate Communications, PolyOne Corporation, +1 440-930-3162, firstname.lastname@example.org; Trade Media Contact: Michelle Maniscalco, Marketing Communications Manager, North America, PolyOne Corporation, +1 440-930-1988, email@example.com